ENDRA Life Sciences (NDRA) Gross Margin (2016 - 2018)

ENDRA Life Sciences (NDRA) posted quarterly Gross Margin of 100.0% for Q1 2018, up 81.94% quarter-over-quarter from 54.96% in Q4 2017.

ENDRA Life Sciences (NDRA) Gross Margin (2016 - 2018) Analysis & Trends

ENDRA Life Sciences (NDRA) has reported Gross Margin for 3 consecutive years, with 100.0% the latest figure, recorded in Q1 2018.

In Q1 2018, Gross Margin changed N/A year-over-year to 100.0%; the TTM figure through Dec 2018 stood at 100.0% (up 4914.0% YoY), while the FY2018 annual figure was 100.0%, up 4914.0% from the prior year.
Gross Margin improved to 100.0% in Q1 2018 per NDRA's latest filing, from 54.96% in the prior quarter.
Across five years, Gross Margin topped out at 100.0% in Q1 2018 and bottomed at 10.98% in Q2 2017.
Historically, Gross Margin has averaged 55.8% across 3 years, with a median of 54.96% in 2017.
On a YoY basis, Gross Margin climbed as much as 71 bps in 2017 and fell as far as 71 bps in 2017.
ENDRA Life Sciences' Gross Margin stood at 54.25% in 2016, then increased by 1 bps to 54.96% in 2017, then soared by 82 bps to 100.0% in 2018.
Business Quant data shows NDRA's Gross Margin at 100.0% in Q1 2018, 54.96% in Q4 2017, and 58.79% in Q3 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Gross Margin (Qtr)
1	Thermo Fisher Scientific	213.40 Bn	209.33 Bn	8.34 Bn	69.57%
2	Danaher	139.94 Bn	135.59 Bn	3.61 Bn	57.64%
3	Idexx Laboratories	46.03 Bn	45.83 Bn	779.09 Mn	64.04%
4	Agilent Technologies	39.69 Bn	37.88 Bn	990.00 Mn	53.95%
5	Iqvia Holdings	39.32 Bn	37.24 Bn	1.44 Bn	32.85%
6	Natera	38.47 Bn	37.37 Bn	696.04 Mn	99.91%
7	Illumina	29.98 Bn	28.82 Bn	770.00 Mn	66.44%
8	Mettler Toledo International	28.57 Bn	28.52 Bn	650.22 Mn	63.29%
9	Quest Diagnostics	26.21 Bn	25.58 Bn	1.03 Bn	33.75%
10	ENDRA Life Sciences	5.44 Mn	5.08 Mn	-	-

Download Data